Your shopping cart is currently empty

IX 207-887 inhibits the release of interleukin-1 (IL-1). IX 207-887 is a novel antiarthritic agent.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $88 | 5 days | 5 days |
| Description | IX 207-887 inhibits the release of interleukin-1 (IL-1). IX 207-887 is a novel antiarthritic agent. |
| In vitro | IX 207-887 is a novel antiarthritic agent that does not affect human monocyte adherence or significantly inhibit IL-1 or IL-2-induced thymocyte proliferation. It lacks IL-1 antagonistic activity in chondrocyte tests but effectively inhibits IL-1 release from human monocytes and mouse peritoneal macrophages, significantly reducing both biologically active and immunoreactive IL-1 in culture media, while IL-1 levels in homogenates or lysates remain largely unchanged or slightly reduced. |
| Molecular Weight | 284.33 |
| Formula | C16H12O3S |
| Cas No. | 98320-39-9 |
| Smiles | C(C(O)=O)=C1C2=C(C(OC)=CC=3C1=CC=CC3)SC=C2 |
| Relative Density. | 1.37 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.